Discovery and validation of urinary biomarkers for prostate cancer - Wikidata - awgldk - TriplyDB

Discovery and validation of urinary biomarkers for prostate cancer

Discovery and validation of urinary biomarkers for prostate cancer

http://www.wikidata.org/entity/Q30438582

about

Proteomics and peptidomics: moving toward precision medicine in urological malignancies Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics.Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Biomarker analysis for prostate cancer diagnosis using LC-MS and CE-MS.Urine collection and processing for protein biomarker discovery and quantification.Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Fibrinogen alpha chain precursor and apolipoprotein A-I in urine as biomarkers for noninvasive diagnosis of calcium oxalate nephrolithiasis: a proteomics study Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.Application of proteomics to cancer early detection Current peptidomics: applications, purification, identification, quantification, and functional analysis Advances in urinary protein biomarkers for urogenital and non-urogenital pathologies.State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics.Current state of the art for enhancing urine biomarker discovery.An individual urinary proteome analysis in normal human beings to define the minimal sample number to represent the normal urinary proteome.The present and future of prostate cancer urine biomarkers.Amyloid-β Precursor Protein Modulates the Sorting of Testican-1 and Contributes to Its Accumulation in Brain Tissue and Cerebrospinal Fluid from Patients with Alzheimer Disease.Optimization for peptide sample preparation for urine peptidomics Urinary proteomics--a tool for biomarker discovery.CE-MS in biomarker discovery, validation, and clinical application.Systematic antibody and antigen-based proteomic profiling with microarrays.Urinary proteomics in cardiovascular disease: Achievements, limits and hopes.Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.Clinical application of urinary proteomics/peptidomics.Developments in coupled solid-phase extraction-capillary electrophoresis 2009-2011.Proteomics in hypertension and other cardiovascular diseases.Toward the detection of prostate cancer in urine: a critical analysis.Biomarkers for the diagnosis of new and recurrent prostate cancer.Novel approaches for the identification of biomarkers of aggressive prostate cancer Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.Clinical proteomics in obstetrics and neonatology.Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.CE-MS-based proteomics in biomarker discovery and clinical application.Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.

P2860

Q26749401-790EE612-604F-43DC-BDD7-CDE9B216D46C Q26752864-AB198B68-73CF-448C-B67A-B1C52F78E485 Q28475613-84B672AF-4D74-4A02-992B-C71CCDC8C09E Q28477629-8DF66EB2-F467-43B5-9B71-156E6A38F9E3 Q28534235-026813E2-5AC4-49A5-B9DB-D3798A4A51FD Q30437141-0B59D1D9-33B2-472A-A442-C0139B9D9AE6 Q30438814-71BE69D6-24F8-4E23-80D3-04FC7BF0E6EC Q31148183-178AD20B-0FCD-423D-A3D9-B40ACCB72048 Q33436829-49BB4CA5-653B-46EB-A8A6-BD08661DFDC0 Q33451945-F24F895E-DBC1-4B7A-97FD-17FF75C9C8D8 Q33780855-D003C798-FF93-48A0-BC5E-1F414DA80472 Q33781011-1D27FCAC-1FB1-41E4-8A37-00E6F756BC9C Q33985444-31F7A66E-9FA9-4DDB-9B8A-52BDAE43E7A5 Q34043307-CAC5C77C-3D9B-4B37-B540-32A11F64C0EF Q34691573-350BEF26-59FA-44BD-B37E-2B9468AE92A9 Q35053031-6F2697E8-7699-42B1-A20D-DF6B9B94499D Q35212347-B2A4C034-B3B1-484D-8E83-E6F8C6E01D3B Q35460015-03220E9A-0568-4CAC-82F3-4335BBBA4800 Q35570959-7F2380A3-D776-46BC-A517-6C1E988A23B9 Q36032361-183556E3-E8FA-4BAC-91F6-6233781BB1BC Q36531291-2FFB4700-3D3F-4407-A710-E02F4AE6E681 Q37007392-FB17C51D-563A-4FF3-B7BE-927D5476853E Q37241399-F960FE73-C14C-4D9F-95F2-BB96BA9F2AB6 Q37621867-B2C472B8-49DE-494C-A54B-366272619DBB Q37701845-30E3015B-CBA5-4D4E-A0D4-C161FE77454A Q37833587-268D0722-A669-457D-8F35-1DD39AAA4CAB Q37853185-BDF59682-F7D0-452F-B7E7-27853C275E8F Q37869464-F5F22C7F-A85B-4372-ABA3-020183F4E229 Q37876853-B2E683A3-3A83-43F6-9462-43E61C44673F Q37945790-CF252B24-E6CA-4625-B552-8CC6CCAB1538 Q37962484-5333BB78-2E16-43A1-8B6E-679D6465E090 Q38020003-9F34B10C-964B-4842-9B46-FC48F1940DC9 Q38047103-A28F65E2-BC9F-40E1-B9E6-E855A02A2C64 Q38052926-92C5D263-B57B-4A43-9754-4B3E6236FBF6 Q38117841-A93896B5-62B6-4674-9866-F80F3D628227 Q38130892-F3ABD0D2-A480-4AD0-B32B-F838A6694CE5 Q38176934-1E184D74-7AFC-422F-ADF8-B4F390492746 Q38340351-6C919962-1D56-4F0A-B9A7-A72031688606 Q38340358-0C35F314-688D-49DE-9F52-79FEE3032842 Q38613772-9A3D556C-CECB-4FDC-B05C-B2B120F6E988

P2860

Discovery and validation of urinary biomarkers for prostate cancer

http://www.wikidata.org/entity/Q30438582

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Discovery and validation of urinary biomarkers for prostate cancer

@ast

Discovery and validation of urinary biomarkers for prostate cancer

@en

type

label

Discovery and validation of urinary biomarkers for prostate cancer

@ast

Discovery and validation of urinary biomarkers for prostate cancer

@en

prefLabel

Discovery and validation of urinary biomarkers for prostate cancer

@ast

Discovery and validation of urinary biomarkers for prostate cancer

@en

P1433

Q30438582-FEB5D4A8-053F-4817-8A20-2899EA1037F7

P1476

Q30438582-C785F955-CFA9-4373-91BD-73F04200D7D2

P2093

Q30438582-028C5945-83C3-47C8-BD5F-1069C6DA6810

Q30438582-06046C5D-7BCE-46E9-B565-2055FD1361EF

Q30438582-0F488A78-EC6E-459E-A33C-56A6347948B0

Q30438582-23C1814A-C88A-4F07-AD4E-7465EAD0313F

Q30438582-53B07173-0006-4830-83A9-A6A9CF931DF1

Q30438582-78133BDE-E524-4AAD-A78A-119BD1FBAE46

Q30438582-7CFDF98A-7228-46DC-9540-5DD5CB2CDF35

Q30438582-A4BC57FD-FCAB-4A6F-B29C-982F15044320

Q30438582-BBBE3737-FBE6-4372-8A63-F6DBD60149C9

Q30438582-F8E7D06F-1DCD-4A3C-AF53-41703A1B8B56

P2860

Q30438582-0433A67A-41C0-43C2-AF22-259435BA7B5D

Q30438582-072F0D3A-10D5-4076-8681-BA49EF7C62D6

Q30438582-0BF53B51-2C3A-488C-ACC1-3EEDC14F3093

Q30438582-1006A54D-F457-4FC4-B598-A9BD685D8AB3

Q30438582-11CE3EF1-3DE1-4382-9E3A-3E52C6C0FDA3

Q30438582-14BF9C36-2749-45FA-AB36-9457735AEBE7

Q30438582-1DA51134-883B-47C8-931F-8CF48513AFD5

Q30438582-1E03AE67-1889-4D2B-A25F-AC72803A7183

Q30438582-28E51DEF-2E11-49AD-B2FC-F1BD6026A6F9

Q30438582-298F7E5F-F925-4E12-8BD6-9E0D2697C229

P304

Q30438582-BCD122F4-7C1E-4845-BBA2-FEDC4C31F5BF

P31

Q30438582-DBFB9DE3-C030-4B52-B1B5-43868AFAEF7A

P356

Q30438582-DC9EE18C-05EC-4BB3-8915-3FF36AA761C0

P433

Q30438582-C90C1C36-79F5-4435-A8C2-58B1CB99495B

P478

Q30438582-4AAAD556-09AE-423A-9955-46379B65EBC0

P50

Q30438582-0F1F96B6-12A1-4BFF-B817-02D48637289A

Q30438582-7101378E-A75A-495C-8DC8-BE7586834835

P577

Q30438582-5F8CA872-09B5-401E-B61D-B96F292E8F35

P5875

Q30438582-69664EE3-07CC-4BF6-9A0E-F624BDD66E63

P698

Q30438582-8545616D-38CC-4F80-9E49-1959E799E93B

P921

Q30438582-E7BFFDF6-07E8-4A02-B61A-68F2796CC6B6

P932

Q30438582-F96CA953-851C-4F6D-823F-7D61EBF06BD9

P356

P1433

Proteomics - Clinical Applications

P1476

Discovery and validation of urinary biomarkers for prostate cancer

@en

P2093

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

David M Good

http://www.w3.org/2001/XMLSchema#string

Eric Schiffer

http://www.w3.org/2001/XMLSchema#string

Frank Eichhorn

http://www.w3.org/2001/XMLSchema#string

Friedrich Douwes

http://www.w3.org/2001/XMLSchema#string

Hartwig W Bauer

http://www.w3.org/2001/XMLSchema#string

Joshua J Coon

http://www.w3.org/2001/XMLSchema#string

Reinhard Polley

http://www.w3.org/2001/XMLSchema#string

Thomas Schmidt

http://www.w3.org/2001/XMLSchema#string

Wolfgang Schöfer

http://www.w3.org/2001/XMLSchema#string

P2860

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry.

Knowledge-based analysis of microarray gene expression data by using support vector machines

Tissue inhibitors of metalloproteinases: evolution, structure and function

Early identification of individuals with prostate cancer in negative biopsies

Detection of prostate cancer with a blood-based assay for early prostate cancer antigen

Cancer statistics, 2006

The minimum information about a proteomics experiment (MIAPE)

How matrix metalloproteinases regulate cell behavior

Cloning of the gene encoding a protective Mycobacterium tuberculosis secreted protein detected in vivo during the initial phases of the infectious process.

Electron transfer dissociation of peptide anions.

P304

556-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.200780082

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229670067

http://www.w3.org/2001/XMLSchema#string

P698

19759844

http://www.w3.org/2001/XMLSchema#string

P921

P932

2744126

http://www.w3.org/2001/XMLSchema#string